A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Thomas Jefferson University
University of Alabama at Birmingham
University of Utah
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Nohla Therapeutics, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
New York Medical College
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Baylor College of Medicine
SWOG Cancer Research Network
Mesoblast, Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
Northwestern University
The Korean Society of Pediatric Hematology Oncology
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center